These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 3884566

  • 1. Treatment of neutropenic infection: a randomized trial comparing latamoxef (moxalactam) with cephradine plus tobramycin.
    Bezwoda WR, Derman DP, Perkins S, Cassel R.
    J Antimicrob Chemother; 1985 Feb; 15(2):239-45. PubMed ID: 3884566
    [Abstract] [Full Text] [Related]

  • 2. Empirical treatment of febrile, neutropenic patients with tobramycin and latamoxef.
    Rhodes EG, Harris RI, Welch RS, Perry DJ, Brown RM, Boughton BJ.
    J Hosp Infect; 1987 May; 9(3):278-84. PubMed ID: 2886533
    [Abstract] [Full Text] [Related]

  • 3. Preservation of colonization resistance parameters during empiric therapy with aztreonam in the febrile neutropenic patient.
    Louie TJ, Chubb H, Bow EJ, Conly JM, Harding GK, Rayner E, James M.
    Rev Infect Dis; 1985 May; 7 Suppl 4():S747-61. PubMed ID: 3909333
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
    Rotstein C, Cimino M, Winkey K, Cesari C, Fenner J.
    Am J Med; 1988 Jul 25; 85(1A):36-43. PubMed ID: 3041817
    [Abstract] [Full Text] [Related]

  • 7. Comparative efficacy and toxicity of moxalactam and the combination of nafcillin and tobramycin in febrile granulocytopenic patients.
    Alanis A, Rehm S, Weinstein AJ.
    Cleve Clin Q; 1983 Jul 25; 50(4):385-95. PubMed ID: 6365358
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Moxalactam versus clindamycin plus tobramycin for the treatment of puerperal infections.
    Pastorek JG, Faro S, Aldridge KE, Nicaud SK.
    South Med J; 1987 Sep 25; 80(9):1116-9. PubMed ID: 3306943
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Management of bacterial infections in severely neutropenic subjects.
    Vincent PC, Fabre S, Jennis F.
    Med J Aust; 1977 Oct 08; 2(3 Pt 2 Suppl):30-3. PubMed ID: 244772
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ceftazidime in the treatment of febrile immunosuppressed children.
    Darbyshire PJ, Williamson PJ, Pedler SJ, Speller DC, Mott MG, Oakhill A.
    J Antimicrob Chemother; 1983 Jul 08; 12 Suppl A():357-60. PubMed ID: 6352644
    [Abstract] [Full Text] [Related]

  • 17. A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignancies.
    Lawson RD, Gentry LO, Bodey GP, Keating MJ, Smith TL.
    Am J Med Sci; 1984 Jul 08; 287(1):16-23. PubMed ID: 6367466
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tobramycin-cephalothin treatment in leukaemic and neutropenic patients with severe infection.
    Papayannis AG, Thomopoulos D, Voulgaris E, Scliros P, Gardikas C.
    J Antimicrob Chemother; 1977 Jul 08; 3(4):311-5. PubMed ID: 893240
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.